Among the most rapidly growing sub-disciplines in the biotechnology industry are the management and manipulation of data, the creation of code for bioinformatics and personalization of medicine, and the creation of Apps. This Roundtable will explore how this digital innovation and ownership is protected.
As a first time principal investigator (PI), the logistics of setting up your first lab can be daunting. From ordering equipment and supplies to recruiting the members who will work beside you, there are considerations to be made that most would not be immediately prepared for.
Join us as we dive into these issues and more, with an emphasis on answering the questions you might have as you prepare to begin your journey as a PI.
Ensuring the proper curation and integrity of data from the earliest stages of collection is absolutely essential. For the quality of downstream results to be trusted, bias must be minimized and accounted for through thoughtful quality control methodologies. Join us as we explore how to best manage this critical concern.
As we continue forward in the age of digital information, the risks to personal privacy and security will only continue to increase. As more technologies provide opportunities for the misuse and release of information, ensuring proper protocols for the anonymization and thoughtful handling of data is paramount. If we are to innovate we must take take great care to protect the individual along the way.
Taking discoveries through to patients is a complex process, engaging scale-up, recruitment, and study design. By leveraging relationships between sponsors, CROs, and research sites, professionals are driving flexible outcomes to current regulatory, scientific, and manufacturing challenges. We bring together professionals across translational and clinical research, as well as patient groups supporting services.